LU69542A1 - - Google Patents
Info
- Publication number
- LU69542A1 LU69542A1 LU69542A LU69542A LU69542A1 LU 69542 A1 LU69542 A1 LU 69542A1 LU 69542 A LU69542 A LU 69542A LU 69542 A LU69542 A LU 69542A LU 69542 A1 LU69542 A1 LU 69542A1
- Authority
- LU
- Luxembourg
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
- C07C251/72—Hydrazones
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1073673A GB1407658A (en) | 1973-03-06 | 1973-03-06 | Process for the manufacture of indole derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| LU69542A1 true LU69542A1 (ja) | 1974-06-21 |
Family
ID=9973351
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LU69542A LU69542A1 (ja) | 1973-03-06 | 1974-03-04 |
Country Status (15)
| Country | Link |
|---|---|
| JP (1) | JPS5058083A (ja) |
| AT (1) | AT333747B (ja) |
| BE (1) | BE811657A (ja) |
| DD (1) | DD110273A5 (ja) |
| DE (1) | DE2410699A1 (ja) |
| DK (1) | DK134403B (ja) |
| ES (1) | ES423958A1 (ja) |
| FR (1) | FR2220528B1 (ja) |
| GB (1) | GB1407658A (ja) |
| IE (1) | IE38970B1 (ja) |
| LU (1) | LU69542A1 (ja) |
| MC (1) | MC1017A1 (ja) |
| NL (1) | NL7402369A (ja) |
| PL (1) | PL91000B1 (ja) |
| YU (1) | YU55774A (ja) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE0200356D0 (sv) * | 2002-02-05 | 2002-02-05 | Astrazeneca Ab | Novel use |
| GB0324763D0 (en) | 2003-10-23 | 2003-11-26 | Oxagen Ltd | Use of compounds in therapy |
| DK2046740T3 (da) | 2006-07-22 | 2012-08-20 | Oxagen Ltd | Forbindelser med CRTH2-antagonistisk virkning |
| PT2250161E (pt) | 2008-01-18 | 2014-01-21 | Atopix Therapeutics Ltd | Compostos tendo atividade antagonista de crth2 |
| WO2009093029A1 (en) | 2008-01-22 | 2009-07-30 | Oxagen Limited | Compounds having crth2 antagonist activity |
| US20100022613A1 (en) | 2008-01-22 | 2010-01-28 | Oxagen Limited | Compounds Having CRTH2 Antagonist Activity |
| GB201322273D0 (en) | 2013-12-17 | 2014-01-29 | Atopix Therapeutics Ltd | Process |
-
1973
- 1973-03-06 GB GB1073673A patent/GB1407658A/en not_active Expired
-
1974
- 1974-02-05 IE IE21274A patent/IE38970B1/xx unknown
- 1974-02-06 ES ES423958A patent/ES423958A1/es not_active Expired
- 1974-02-21 NL NL7402369A patent/NL7402369A/xx unknown
- 1974-02-26 DK DK102074A patent/DK134403B/da unknown
- 1974-02-27 BE BE141465A patent/BE811657A/xx unknown
- 1974-03-04 LU LU69542A patent/LU69542A1/xx unknown
- 1974-03-04 YU YU55774A patent/YU55774A/xx unknown
- 1974-03-04 PL PL16924274A patent/PL91000B1/pl unknown
- 1974-03-04 DD DD17692974A patent/DD110273A5/xx unknown
- 1974-03-05 FR FR7407494A patent/FR2220528B1/fr not_active Expired
- 1974-03-05 MC MC1099A patent/MC1017A1/xx unknown
- 1974-03-05 AT AT182374A patent/AT333747B/de not_active IP Right Cessation
- 1974-03-06 JP JP2609874A patent/JPS5058083A/ja active Pending
- 1974-03-06 DE DE19742410699 patent/DE2410699A1/de active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5058083A (ja) | 1975-05-20 |
| MC1017A1 (fr) | 1975-02-28 |
| DD110273A5 (ja) | 1974-12-12 |
| FR2220528B1 (ja) | 1977-09-23 |
| ATA182374A (de) | 1976-04-15 |
| IE38970L (en) | 1974-09-06 |
| NL7402369A (ja) | 1974-09-10 |
| DE2410699A1 (de) | 1974-09-12 |
| GB1407658A (en) | 1975-09-24 |
| DK134403C (ja) | 1977-03-28 |
| DK134403B (da) | 1976-11-01 |
| IE38970B1 (en) | 1978-07-05 |
| AT333747B (de) | 1976-12-10 |
| FR2220528A1 (ja) | 1974-10-04 |
| PL91000B1 (en) | 1977-02-28 |
| ES423958A1 (es) | 1976-05-16 |
| BE811657A (fr) | 1974-08-27 |
| YU55774A (en) | 1982-06-30 |